AI assistant
Anteris Technologies Global Corp. — Capital/Financing Update 2019
May 30, 2019
33869_rns_2019-05-30_36b02cd3-8ce7-4877-95e1-e0b4732c365d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
31 May 2019
==> picture [451 x 24] intentionally omitted <==
ASX ANNOUNCEMENT
Admedus completes sale of part of Infusion business
Structural heart company Admedus Ltd (ASX: AHZ) confirms completion of the sale of part of its Infusion business to BTC Speciality Health Pty Ltd, a wholly owned subsidiary of BTC Health Limited (ASX: BTC) for A$6.3 million.
ENDS
For more information, please contact: [email protected]
About Admedus Limited
Admedus (ASX: AHZ) is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next-generation technologies with world-class partners and acquiring strategic assets to grow product and service offerings. The Company has assets from research & development through clinical development and sales, marketing and distribution.
Website: www.admedus.com
Facebook: www.facebook.com/Admedus Twitter: @Admedus
Admedus Limited
==> picture [72 x 72] intentionally omitted <==
Registered Office: Toowong Tower, Level 3, 9 Sherwood Rd, Toowong, Queensland 4066 Customer Service:
T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: [email protected] W: admedus.com
Brisbane • Minneapolis • Geneva • Singapore
ABN 35 088 221 078